Yao, J., Zang, W., Ge, Y., Weygant, N., Yu, P., Li, L., . . . An, G. RAS/BRAF Circulating Tumor DNA Mutations as a Predictor of Response to First-Line Chemotherapy in Metastatic Colorectal Cancer Patients. Wiley.
Chicago Style (17th ed.) CitationYao, Jiannan, et al. RAS/BRAF Circulating Tumor DNA Mutations as a Predictor of Response to First-Line Chemotherapy in Metastatic Colorectal Cancer Patients. Wiley.
MLA (9th ed.) CitationYao, Jiannan, et al. RAS/BRAF Circulating Tumor DNA Mutations as a Predictor of Response to First-Line Chemotherapy in Metastatic Colorectal Cancer Patients. Wiley.
Warning: These citations may not always be 100% accurate.